evans blue has been researched along with Inadequate Sleep in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Esqueda-León, E; Gómez-González, B; Hurtado-Alvarado, G; Rojas-Zamorano, JÁ; Santana-Miranda, R; Velázquez-Moctezuma, J | 1 |
Buzoianu, AD; Lafuente, JV; Muresanu, DF; Patnaik, R; Sharma, A; Sharma, HS; Tian, ZR | 1 |
2 other study(ies) available for evans blue and Inadequate Sleep
Article | Year |
---|---|
REM sleep loss and recovery regulates blood-brain barrier function.
Topics: Animals; Blood-Brain Barrier; Evans Blue; Male; Random Allocation; Rats; Rats, Wistar; Recovery of Function; Sleep Deprivation; Sleep, REM | 2013 |
Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT3 Receptor Antagonist Ondansetron.
Topics: Animals; Blood Proteins; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Cognition Disorders; Coloring Agents; Copper; Drug Evaluation, Preclinical; Drug Implants; Evans Blue; Fatigue; Iodine Radioisotopes; Male; Nanoparticles; Nanowires; Neuroprotective Agents; Ondansetron; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Sensation Disorders; Serotonin; Serotonin 5-HT3 Receptor Agonists; Silver; Sleep Deprivation; Time Factors | 2015 |